Number of the records: 1  

Depletion of Treg cells inhibits minimal residual disease after surgery of HPV16-associated tumours

  1. 1.
    SYSNO ASEP0044812
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleDepletion of Treg cells inhibits minimal residual disease after surgery of HPV16-associated tumours
    TitleDeplece regulačních T buněk potlačuje minimálni zbytkovou chorobu po chirurgickém odstranění nádorů asociovaných s HPV16
    Author(s) Šímová, Jana (UMG-J) RID
    Bubeník, Jan (UMG-J)
    Bieblová, Jana (UMG-J)
    Rosalia, Rodney Alexander (UMG-J)
    Frič, Jan (UMG-J)
    Reiniš, Milan (UMG-J) RID
    Source TitleInternational Journal of Oncology. - : Spandidos Publications - ISSN 1019-6439
    Roč. 29, č. 6 (2006), s. 1567-1571
    Number of pages5 s.
    Languageeng - English
    CountryGR - Greece
    KeywordsHPV16 ; residual tumour disease ; Treg cells
    Subject RIVEB - Genetics ; Molecular Biology
    R&D ProjectsGA301/04/0492 GA ČR - Czech Science Foundation (CSF)
    CEZAV0Z50520514 - UMG-J (2005-2011)
    AnnotationIt is generally accepted that T regulatory cells (Treg CD4+CD25+Foxp3+) play an important role in the suppression of tumour immunity. We examined the impact of Treg cell depletion with anti-CD25 antibody as adjuvant therapy in the treatment of minimal residual disease after excision of murine HPV16-associated tumours. We found that the depletion of Treg cells inhibited growth of the recurrences after surgery of HPV16-associated MHC class I+ as well as MHC class I-deficient tumours transplanted in syngeneic mice. These results demonstrate that depletion of CD25+CD4+ Treg cells can be used as an efficient adjuvant treatment improving the results of surgery in the experimental systems mimicking human MHC class I+ and MHC class I-deficient, HPV16-associated neoplasms. Therefore, this therapeutic modality is worth being examined in patients with minimal residual HPV16-associated tumour disease after surgery.
    WorkplaceInstitute of Molecular Genetics
    ContactNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2007
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.